comparemela.com

Latest Breaking News On - Daniela macuga - Page 1 : comparemela.com

USANA Health Sciences, Inc (NYSE:USNA) Short Interest Down 19 6% in April

USANA Health Sciences, Inc (NYSE:USNA) Short Interest Down 19 6% in April
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

3,368 Shares in USANA Health Sciences, Inc (NYSE:USNA) Acquired by Ifrah Financial Services Inc

3,368 Shares in USANA Health Sciences, Inc (NYSE:USNA) Acquired by Ifrah Financial Services Inc
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Signaturefd LLC Has $90,000 Stock Holdings in USANA Health Sciences, Inc (NYSE:USNA)

Signaturefd LLC grew its holdings in USANA Health Sciences, Inc. (NYSE:USNA – Free Report) by 123.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,424 shares of the company’s stock after buying an additional 787 shares during the quarter. Signaturefd LLC’s […]

USANA Health Sciences (NYSE:USNA) Announces Earnings Results, Beats Expectations By $0 19 EPS

USANA Health Sciences (NYSE:USNA) Announces Earnings Results, Beats Expectations By $0 19 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

USANA Health Sciences (NYSE:USNA) Updates FY 2023 Earnings Guidance

USANA Health Sciences (NYSE:USNA – Get Free Report) issued an update on its FY 2023 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $2.65-$3.30 for the period, compared to the consensus earnings per share estimate of $3.02. The company issued revenue guidance of $900.00 million-$950.00 million, compared to the consensus […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.